Abstract
Approximately 150 recurrent chromosomal aberrations have been described in hematologic neoplasms (1). Many are associated with certain morphologic, immunologic, or clinical subtypes of leukemia and lymphoma. Some are of clear-cut biological importance, and about 50 specific translocations and inversions have been shown to cause gene fusions that activate cancer genes (2). To investigate the fundamental biological question of stem cells, and in view of therapeutic considerations, it is essential to identify the malignant cells among the numerous cell types in the hematopoietic system. Chromosomal aberrations are excellent cancer-specific markers. Phenotypic markers can be also used to characterize the cell lineages and stages of differentiation of malignant cells. Hematopoietic cells and malignancies are typically classified according to cell morphology and immunophenotype (3).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Heim S, Mitelman F: Cancer Cytogenetics New York: Liss, 1995.
Rabbitts TH: Chromosomal translocations in human cancer. Nature 372:143–149, 1994.
Second MIC Cooperative Study Group: Morphologic, immunologic and cytogenetic (MIC) working classification of the acute myeloid leukaemias. Br J Haematol 68:487–494, 1988.
Teerenhovi L, Knuutila S, Ekblom M, Rossi L, Borgström GH, Tallman JK, Andersson L, de la Chapelle A: A method for simultaneous study of the karyotype, morphology, and immunologic phenotype of mitotic cells in hematologic malignancies. Blood 64:1116–1122, 1984.
Knuutila S, Keinänen M: Chromosome banding techniques for morphologically classified cells. Cytogenet Cell Genet 39:70–72, 1985.
Wessman M, Knuutila S: A method for the determination of cell morphology, immunologic phenotype and numerical chromosomal abnormalities on the same mitotic or interphase cell. Genet (Life Sci Adv) 7:127–130, 1988.
Knuutila S, Teerenhovi L: Immunophenotyping of aneuploid cells. Cancer Genet Cytogenet 41:1–17, 1989.
Tiainen M, Popp S, Parlier V, Emmerich P, Jotterand Bellomo M, Ruutu T, Cremer T, Knuutila S: Chromosomal in situ suppression hybridization of immunologically classified mitotic cells in hematologic malignancies. Genes Chromosom Cancer 4:135–140, 1992.
Larramendy ML, Kovanen PE, Knuutila S: MAC (morphology, antibody, chromosomes) method for study of cell proliferation in unfractionated human hematopoietic cell cultures. J Histotechnol 15:31–38, 1992.
Knuutila S: Morphology antibody chromosome technique for determining phenotype and genotype of the same cell. Unit 4.7. In: Boyle AL (ed.), Current Protocols in Human Genetics. Madison CT: Wiley, 1996.
Knuutila S, Nylund SJ, Wessman M, Larramendy ML: Analysis of genotype and phenotype on the same interphase or mitotic cell. A manual of MAC (morphology antibody chromosomes) methodology. Cancer Genet Cytogenet 72:1–15, 1994.
Knuutila S, Alitalo R, Ruutu T: Power of the MAC (morphology antibody chromosomes) method in distinguishing reactive and clonal cells: Report of a patient with acute lymphatic leukemia, eosinophilia and t(5;14). Genes Chromosom Cancer 8:219–223, 1993.
Stenman S, Rosenqvist M, Ringertz R: Preparation and spread of unfixed metaphase chromosomes for immunofluorescence staining of nuclear antigens. Exp Cell Res 90:87–94, 1975.
van den Berg H, Vossen JM, Langlois van den Bergh R, Bayer J, van Tol MJD: Detection of Y chromosome by in situ hybridization in combination with membrane antigens by two-color immunofluorescence. Lab Invest 64:623–628, 1991.
Kibbelaar RE, van Kamp H, Dreef EJ, de Groot-Swings G, Kluin-Nelemans JC, Beverstock GC, Fibbe WE, Kluin PM: Combined immunophenotyping and DNA in situ hybridization to study lineage involvement in patients with myelodysplasia syndromes. Blood 79:1823–1828, 1992.
Weber-Matthiesen K, Winkemann M, Müller-Hermelink A, Schlegelberger B, Grote W: Simultaneous fluorescence immunophenotyping and interphase cytogenetics: a contribution to the characterization of tumor cells. J Histochem Cytochem 40:171–175, 1992.
Anastasi J, Vardiman JW, Rudinsky R, Patel M, Nachman J, Rubin CM, Le Beau MM: Direct correlation of cytogenetic findings with cell morphology using in situ hybridization: an analysis of suspicious cells in bone marrow specimens of two patients completing therapy for acute lymphoblastic leukemia. Blood 77:2456–2462, 1991.
Price CM, Kanfer EJ, Colman SM, Westwood N, Barrett AJ, Greaves MF: Simultaneous genotypic and immunophenotypic analysis of interphase cells using dual-color fluorescence: a demonstration of lineage involvement in polycythemia vera. Blood 80:1033–1038, 1992.
Fialkow PJ, Denman AM, Jacobson RJ, Lowenthal MN: Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells. J Clin Invest 62:815–823, 1978.
Martin PJ, Najfeld V, Hansen JA, Penfold GK, Jacobson RJ, Fialkow PJ: Involvement of the B-lymphoid system in chronic myelogenous leukemia. Nature 287:49,50, 1980.
Munker R, Miller CW, Berenson J, Dreazen O, Koeffler HP: A Ph1 chromosome positive B cell line expresses the fusion protein P 210. Nouv Rev Fr Hematol 31:39–43, 1989.
Knuutila S, Lindlöf M, Kovanen PE, Ramqvist T, Ruutu T, Andersson LC: Philadelphia chromosome as the sole abnormality and p210 bcr-abl chimeric protein expression in an Epstein-Barr virus-transformed B cell line from a patient with chronic myeloid leukemia. Acta Haematol 90:190–194, 1993.
Bartram CR, de Klein A, Hagemeijer A, van Agthoven T, van Kessel AG, Bootsma D, Grosveld G, Ferguson-Smith MA, Davies T, Stone M, Heisterkamp N, Stephenson JR, Groffen J: Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia. Nature 306:277–280, 1983.
Jonas D, Lübbert M, Kawasaki ES, Henke M, Bross KJ, Mertelsmann R, Herrmann F: Clonal analysis of bcr-abl rearrangement in T lymphocytes from patients with chronic myelogenous leukemia. Blood 79:1017–1023, 1992.
Knuutila S, Larramendy M, Ruutu T, Heiander T: Involvement of natural killer cells in chronic myeloid leukemia. Cancer Genet Cytogenet 79:21–24, 1995.
Ferraris AM, Raskind WH, Bjornson BH, Jacobson RJ, Singer JW, Fialkow PJ: Heterogeneity of B cell involvement in acute nonlymphocytic leukemia. Blood 66:342–344, 1985.
Boehm TL, Werle A, Drahovsky D: Immunoglobulin heavy chain and T-cell receptor gamma and beta chain gene rearrangements in acute myeloid leukemias. Mol Biol Med 4:51–62, 1987.
Janssen JWG, Buschle M, Layton M, Drexler HG, Lyons J, van den Berghe H, Heimpel H, Kubanek B, Kleihauer E, Mufti GJ, Bartram CR: Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin. Blood 73:248–254, 1989.
Leone R, Lo Coco F, De Rossi G, Diverio D, Frontani M, Spadea A, Testi AM, Cordone I, Mandelli F: Immunoglobulin heavy chain and T-cell receptor beta chain gene rearrangements in acute non lymphoid leukemia. Haematologica 75:125–128, 1990.
Buccheri V, Matutes E, Dyer MJ, Catovsky D: Lineage commitment in biphenotypic acute leukemia. Leukemia 7:919–297, 1993.
Tsukamoto N, Morita K, Maehara T, Okamoto K, Karasawa M, Omine M, Naruse T: Clonality in myelodysplastic syndromes: demonstration of pluripotent stem cell origin using X-linked restriction fragment length polymorphisms. Br J Haematol 83:589–594, 1993.
El-Rifai W, Larramendy ML, Ruutu T, Knuutila S: Lymphoid involvement in a patient with acute myeloid leukemia: a direct phenotypic and genotypic study of single cells. Genes Chromosom Cancer 15:34–37, 1996.
El-Rifai W, Pettersson T, Larramendy ML, Knuutila S: Lineage involvement and karyotype in a patient with myelodysplasia and blood basophilia. Eur J Haematol 53:288–292, 1994.
Han K, Lee W, Harris CP, Kim W, Shim S, Meisner LF: Quantifying chromosome changes and lineage involvement in myelodysplastic syndrome (MDS) using fluorescent in situ hybridization (FISH). Leukemia 8:81–86, 1994.
Fugazza G, Bruzzone R, Dejana AM, Gobbi M, Ghio R, Patrone F, Rattenni S, Sessarego M: Cytogenetic clonality in chronic myelomonocytic leukemia studied with fluorescence in situ hybridization. Leukemia 9:109–114, 1995.
Kere J, Knuutila S, Ruutu T, Leskinen R, de la Chapelle A: Monocytic involvement by monosomy 7 preceded acute myelomonocytic leukemia in a patient with myelodysplastic syndrome. Leukemia 2:69–73, 1988.
van Lorn K, Hagemeijer A, Smit EME, Löwenberg B: In situ hybridization on May-Grünwald-Giemsa-stained bone marrow and blood smears of patients with hematologic disorders allows detection of cell-lineage-specific cytogenetic abnormalities. Blood 82:884–888, 1993.
Knuutila S, Teerenhovi L, Larramendy ML, Elonen E, Franssila K, Nylund SJ, Timonen T, Heinonen K, Mahlamäki E, Winqvist R, Ruutu T: Cell lineage involvement of recurrent chromosomal abnormalities in hematologic neoplasms. Genes Chromosome Cancer 10:95–102, 1994.
Nylund S J, Verbeek W, Larramendy ML, Ruutu T, Heinonen K, Hallman H, Knuutila S: Cell lineage involvement in four patients with myelodysplastic syndrome and t(1;7) or trisomy 8 studied by simultaneous immunopheno-typing and fluorescence in situ hybridization. Cancer Genet Cytogenet 70:120–124,1993.
Parlier V, Tiainen M, Beris P, Miescher PA, Knuutila S, Jotterand Bellomo M: Trisomy 8 detection in granulomonocytic, erythrocytic and megakaryocyte lineages by chromosomal in situ suppression hybridization in a case of refractory anaemia with ringed sideroblasts complicating the course of paroxysmal nocturnal haemoglobinuria. Br J Haematol 81:296–304, 1992.
Knuutila S, Majander P, Ruutu T: 8;21 and 15;17 translocations. Abnormalities in a single cell lineage in acute granulocytic leukemia. Acta Haematol 92:88–90, 1994.
Knuutila S, Larramendy M, Ruutu T, Paetau A, Heinonen K, Mahlamäki E: Analysis of phenotype and genotype of individual cells in neoplasms. Cancer Genet Cytogenet 68:104–113, 1993.
Knuutila S, Elonen E, Teerenhovi L, Rossi L, Leskinen R, Bloomfield CD, de la Chapelle A: Trisomy 12 in B cells of patients with B-cell chronic lymphocytic leukemia. N Engl J Med 314:865–869, 1986.
Autio K, Elonen E, Teerenhovi L, Knuutila S: Cytogenetic and immunologic characterization of mitotic cells in chronic lymphocytic leukaemia. Eur J Haematol 39:289–298, 1987.
Larramendy ML, Peltomäki P, Salonen E, Knuutila S: Chromosomal abnormality limited to T4 lymphocytes in a patient with T-cell chronic lymphocytic leukaemia. Eur J Haematol 45:52–59, 1990.
Knuutila S, El-Rifai W, Larramendy ML, Ruutu T: Direct evidence of involvement of erythroid cells in Ph-positive acute lymphocytic leukemia. Unpublished data.
Larramendy ML, El-Rifai W, Saarinen U, Alitalo R, Luomahaara S, Knuutila S: Myeloid lineage involvement in acute lymphoblastic leukemia: A morphology antibody chromosomes (MAC) study. Exp Hematology 23:1563–1567, 1995.
Franssila KO, Lindholm C, Teerenhovi L, Knuutila S: A method combining morphological, immunocytochemical and chromosomal examinations of the same cell in the study of lymphoproliferative diseases. Eur J Haematol 40:332–338, 1988.
Knuutila S, Lakkala T, Teerenhovi L, Peltomäki P, Kovanen R, Franssila K: t(2;5)(p23;q35)—A specific chromosome abnormality in large cell anaplastic (Ki-1) lymphoma. Leukemia Lymphoma 3:53–59, 1990.
Lindholm C, Franssila KO, Teerenhovi L, Elonen E, Peltomäki P, Rapola J, Ruutu T, Saarinen U, Knuutila S: Characterization of neoplastic and reactive cells in T-cell lymphomas with cytogenetic, surface marker, and DNA methods. Br J Haematol 73:68–75, 1989.
Teerenhovi L, Lindholm C, Pakkala A, Franssila K, Stein H, Knuutila S: Unique display of a pathologic karyotype in Hodgkin’s disease by Reed-Sternberg cells. Cancer Genet Cytogenet 34:305–311, 1988.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Humana Press Inc.
About this chapter
Cite this chapter
Knuutila, S. (1997). Direct Demonstration of Lineage Specificity in Hematologic Neoplasms. In: Wolman, S.R., Sell, S. (eds) Human Cytogenetic Cancer Markers. Contemporary Biomedicine, vol 13. Humana Press. https://doi.org/10.1007/978-1-4612-3952-9_5
Download citation
DOI: https://doi.org/10.1007/978-1-4612-3952-9_5
Publisher Name: Humana Press
Print ISBN: 978-1-4612-8437-6
Online ISBN: 978-1-4612-3952-9
eBook Packages: Springer Book Archive